30 results
8-K
EX-10.1
GANX
Gain Therapeutics Inc
8 Apr 24
Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Officer
4:23pm
8-K
EX-10.1
GANX
Gain Therapeutics Inc
22 Nov 23
Gain Therapeutics Announces Proposed Public Offering
5:27pm
10-Q
2023 Q3
EX-10.3
GANX
Gain Therapeutics Inc
Quarterly report
14 Nov 23
4:05pm
10-Q
2023 Q2
EX-10.3
GANX
Gain Therapeutics Inc
Quarterly report
10 Aug 23
4:06pm
8-K
EX-10.1
GANX
Gain Therapeutics Inc
28 Apr 23
Departure of Directors or Certain Officers
4:10pm
8-K
EX-10.1
zwvkntfw584l
12 Apr 23
Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
4:35pm
8-K
EX-10.1
94m j64jla1
20 Sep 22
GAIN THERAPEUTICS Announces PROMOTION OF Matthias Alder TO chief executive officer
5:28pm
8-K
EX-10.3
krcvtb z96
20 Sep 22
GAIN THERAPEUTICS Announces PROMOTION OF Matthias Alder TO chief executive officer
5:28pm
10-K
EX-10.8
pb00427pm1az1v82
25 Mar 22
Annual report
2:24pm
8-K
EX-10.1
ttjrce smk
28 Dec 21
Departure of Directors or Certain Officers
4:11pm
8-K
EX-10.2
mpd 6c11av
28 Dec 21
Departure of Directors or Certain Officers
4:11pm
S-1/A
EX-10.2
u3at06h6gklly
10 Mar 21
IPO registration (amended)
6:30am
S-1/A
EX-10.1
7sx5t2hvhs6 c7ip
10 Mar 21
IPO registration (amended)
6:30am
S-1
EX-10.3
y0c65085k 2x5i
19 Feb 21
IPO registration
4:21pm
S-1
EX-10.11
vpyd61tu0s1nil6
19 Feb 21
IPO registration
4:21pm
S-1
EX-10.10
otv7zaizw bce2i829o
19 Feb 21
IPO registration
4:21pm
S-1
EX-10.4
udtz6j1q
19 Feb 21
IPO registration
4:21pm
S-1
EX-10.8
w1ui nvdqbqoyu6vsao
19 Feb 21
IPO registration
4:21pm
S-1
EX-10.7
6z4x28sw qflj
19 Feb 21
IPO registration
4:21pm